Login
From:
Synox | Website
(Uncensored)
subscribe
SynOx Therapeutics Completes Enrollment in Registrational Phase 3 TANGENT Clinical Trial Significantly Ahead of Timeline
https://synoxtherapeutics.com/synox-therapeutics-completes-enrollment-in-registrational-phase-3-tangent-clinical-trial-significantly-ahead-of-timeline/
links
backlinks
Tagged with:
press releases
emactuzumab
synox
synox therapeutics
tangent
Top-Line Results from Study Evaluating Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) Expected in First Quarter of 2026
Roast topics
Find topics
Find it!
